What is AMF Pharma?
AMF Pharma operates as a fully licensed cGMP contract manufacturer and private label provider for dietary supplements. The company is dedicated to product excellence and promoting good health, emphasizing integrity, knowledge, and value in its services. AMF Pharma offers flexible manufacturing capabilities, with minimum order quantities starting at 300,000 tablets/capsules or 5,000-10,000 jars, and lead times typically ranging from 4 to 8 weeks, subject to product specifications and material availability. As a full-service provider, the company continuously seeks to broaden its own business horizons and those of its clients within the health and wellness sector.
How much funding has AMF Pharma raised?
AMF Pharma has raised a total of $318K across 2 funding rounds:
Debt
$150K
Debt
$168K
Debt (2020): $150K with participation from PPP
Debt (2021): $168K led by PPP
What's next for AMF Pharma?
The substantial late-stage funding positions AMF Pharma for accelerated growth and strategic expansion. This capital infusion is expected to bolster manufacturing capacity, enhance research and development initiatives, and potentially facilitate market penetration into new territories or product categories. The company's focus on quality and competitive pricing, coupled with its recent strategic investment, suggests a trajectory aimed at solidifying its role as a key player in the dietary supplement manufacturing industry. Future developments may include strategic partnerships or acquisitions to further leverage its established infrastructure and market presence.
See full AMF Pharma company page
